| | | | | | | |
 | MODERNA, INC. | 1.18% | -9.72% | -1.82% | 3.97% | 759.82% | 66 963 |
 | LONZA GROUP AG | 4.91% | -0.19% | 20.64% | -14.62% | 37.51% | 42 273 |
| ALNYLAM PHARMACEUTICALS, INC. | 2.15% | -0.75% | -3.32% | 58.16% | 100.15% | 27 670 |
| SEAGEN INC. | 0.29% | 0.74% | 8.50% | 1.63% | 28.64% | 25 813 |
 | CELLTRION, INC. | 5.07% | 2.72% | 5.79% | 16.95% | 11.35% | 19 820 |
| ICON PUBLIC LIMITED COMPANY | 4.07% | 1.50% | 26.30% | -11.08% | 45.49% | 19 247 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | 1.52% | -5.49% | 12.66% | 14.33% | 61.17% | 14 661 |
| BIO-TECHNE CORPORATION | -0.53% | 1.82% | -2.45% | -22.61% | 54.02% | 12 758 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 4.72% | 3.03% | 19.28% | -24.24% | 68.15% | 12 629 |
| PHARMARON BEIJING CO., LTD. | -1.94% | -12.34% | 7.00% | -7.70% | 86.25% | 12 173 |
| UNITED THERAPEUTICS CORPORATION | -0.20% | -2.23% | -6.69% | 28.38% | 165.67% | 11 850 |
| QIAGEN N.V. | -0.10% | -2.14% | -0.96% | -1.08% | 46.21% | 11 257 |
 | GENSCRIPT BIOTECH CORPORATION | 1.06% | 1.81% | 14.69% | 16.09% | 55.40% | 7 607 |
| MEDPACE HOLDINGS, INC. | 4.78% | -0.33% | 12.26% | 33.88% | 178.73% | 7 059 |
| BACHEM HOLDING AG | -1.53% | -1.65% | 0.75% | -27.39% | 132.78% | 6 497 |
| | | | | | | |
| | Durchschnitt | 1.70% | -1.55% | 7.51% | 4.31% | 122.09% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 2.05% | -2.67% | 7.02% | 4.87% | 219.94% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
